![]() ![]() In June 2016, GE Healthcare launched Capto Q XP, a strong anion exchange chromatography resin. GE Healthcare, the leading chromatography resin company, adopted various strategies such as contracts, new product launches, and investments to widen its product portfolio. (U.S.), and Tosoh Corporation (Japan) to strengthen their market position and widen their product portfolio. New product launches, expansions, contracts & agreements, and acquisitions are some of the strategies adopted by companies such as GE Healthcare (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. The growth of the chromatography resin market in drug discovery was largely influenced by new product launches and expansions during the past five years. These players have adopted various strategies to expand their global presence and increase their market shares. Some of the major players operating in this market include GE Healthcare (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. Browse 101 market data tables and 37 figures spread through 147 pages and in-depth TOC on "Chromatography Resin Market in Drug Discovery" ![]() ![]() The demand for chromatography resins is increasing due to their increasing usage in therapeutic applications. The chromatography resin market in drug discovery is projected to grow from USD 290.7 million in 2017 to USD 401.1 million by 2022, at a CAGR of 6.65% from 2017 to 2022. Chromatography Resin Market in Drug Discovery Leaders & Research Insight. ![]()
0 Comments
Leave a Reply. |